Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Preventing Contamination during Process Transfers – V 2.0

Posted on By

Creams: SOP for Preventing Contamination during Process Transfers – V 2.0

Standard Operating Procedure for Preventing Contamination during Process Transfers

Department Creams
SOP No. SOP/CRM/171/2025
Supersedes SOP/CRM/171/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to outline procedures for preventing contamination during process transfers in cream manufacturing. This includes the transfer of raw materials, intermediate products, and finished products between production stages, ensuring product safety and quality.

2. Scope

This SOP applies to the process transfers within the cream manufacturing process, covering the transfer of raw materials, semi-finished cream batches, and finished products. It ensures that the transfer processes are performed in a controlled manner to prevent contamination.

3. Responsibilities

  • Production Team: Responsible for performing transfers according to the procedure outlined in this SOP, using appropriate equipment and following hygiene protocols to avoid contamination.
  • Quality Control (QC) Team: Responsible for ensuring that all transfer equipment is properly cleaned, inspected, and verified before and after use. QC will also conduct sampling and testing to confirm that no contamination has occurred during the transfer process.
  • Maintenance Team: Responsible for maintaining and calibrating transfer equipment, such as pumps, pipes, and tanks, ensuring
that the equipment is in good condition and free from defects that could contribute to contamination.
  • Laboratory Supervisor: Responsible for overseeing the verification of transfer procedures and ensuring that sampling results meet product specifications for contamination control.
  • 4. Accountability

    The Production Manager is accountable for ensuring that process transfers are carried out according to this SOP. The QC Manager is responsible for ensuring that contamination controls are implemented and verified. The Laboratory Supervisor is accountable for reviewing transfer samples and test results.

    5. Procedure

    5.1 Pre-Transfer Setup

    1. Ensure that all equipment used for transfers, including pumps, pipes, tanks, and transfer lines, are clean, sanitized, and ready for use. Clean-in-place (CIP) procedures should be followed if required.
    2. Verify that the transfer route is clear of obstructions and that all valves, seals, and gaskets are intact.
    3. Confirm that all necessary documentation (e.g., BMR, transfer log) is ready for use and that any required batch-specific information is noted.
    4. Ensure that personal protective equipment (PPE) is worn by all personnel involved in the transfer process to avoid direct contact with the product and ensure hygiene.

    5.2 Process Transfer Procedure

    1. Check the integrity of the transfer equipment to ensure that there are no leaks or damage that could allow contamination during the transfer process.
    2. Ensure that the transfer is carried out in a controlled manner. Use closed systems wherever possible to minimize the risk of contamination from the surrounding environment.
    3. If the transfer involves the movement of semi-finished or finished cream products, ensure that the product is adequately protected from contamination. Ensure that the product is transferred in sealed containers or systems, such as dedicated transfer lines, to prevent exposure to external contaminants.
    4. During the transfer, continuously monitor the process to ensure there are no interruptions or failures in the system that could lead to contamination.

    5.3 Handling Deviations

    1. If any contamination or risk of contamination is detected during the transfer process, stop the transfer immediately and assess the situation.
    2. Identify potential contamination sources such as faulty seals, improper cleaning, or external contamination from the environment.
    3. Document the incident in the Deviation Report (Annexure-1), describing the cause of the contamination, corrective actions taken, and any impact on the batch.
    4. Perform additional cleaning, re-validation, or rework as necessary, and re-sample the product to verify that it is free from contamination before proceeding further with production.

    5.4 Post-Transfer Activities

    1. Once the transfer is complete, verify the integrity of the transferred product by conducting microbiological and chemical testing (if applicable). This ensures that the product has not been contaminated during the process.
    2. If the product passes testing, approve the batch for the next stage in production, such as filling or packaging.
    3. If the batch fails any contamination test, initiate rework or discard the batch as per the Batch Rework SOP (SOP/CRM/004/2025).

    5.5 Cleaning and Sanitation

    1. After each transfer, ensure that the equipment is thoroughly cleaned and sanitized according to the Cleaning SOP (SOP/CRM/005/2025) to prevent cross-contamination between different batches or ingredients.
    2. Verify that cleaning logs are completed accurately and that the equipment is sanitized before the next use.
    3. Ensure that all cleaning agents are properly handled, stored, and disposed of in accordance with safety guidelines.

    5.6 Documentation and Record-Keeping

    1. Document each transfer in the Transfer Log (Annexure-2), including the date, time, transfer equipment used, personnel involved, and any relevant observations.
    2. Record any deviations in the Deviation Report (Annexure-1), along with corrective actions taken and final results.
    3. Ensure that all records are signed by the operator, reviewed by the QC team, and filed according to company retention policies.

    6. Abbreviations

    • GMP: Good Manufacturing Practices
    • QC: Quality Control
    • QA: Quality Assurance
    • BMR: Batch Manufacturing Record
    • PPE: Personal Protective Equipment
    • CIP: Clean-in-Place

    7. Documents

    1. Annexure-1: Deviation Report
    2. Annexure-2: Transfer Log

    8. References

    • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
    • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • FDA Guidance for Industry: Preventing Contamination in Pharmaceutical Manufacturing

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Deviation Report

    Batch Number Deviation Description Corrective Action Resolved By
    12345 Contamination detected during transfer Re-blended and re-tested Jane Smith

    Annexure-2: Transfer Log

    Batch Number Transfer Date Transfer Equipment Transferred By Observations
    12345 20/01/2026 Pump, Pipe John Doe No contamination observed

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/03/2024 1.0 Initial Version New SOP Creation QA Head
    01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
    See also  Creams: SOP for Inspecting Sealing Quality in Cream Packaging Machines - V 2.0
    Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

    Post navigation

    Previous Post: Sterile Injectable Manufacturing: SOP for Intraosseous Injection Batch Manufacturing – V 2.0
    Next Post: Analytical Method Development: Sink Condition Determination SOP – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version